Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298–306.

Article  CAS  PubMed  Google Scholar 

Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 2011;71:5601–5.

Article  CAS  PubMed  Google Scholar 

Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, et al. Strategies for clinical implementation of TNM-immunoscore in resected nonsmall-cell lung cancer. Ann Oncol. 2016;27:225–32.

Article  CAS  PubMed  Google Scholar 

Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, et al. Towards the introduction of the “immunoscore” in the classification of malignant tumours. J Pathol. 2014;232:199–209.

Article  CAS  PubMed  Google Scholar 

Dobbin KK, Cesano A, Alvarez J, Hawtin R, Janetzki S, Kirsch I, et al. Validation of biomarkers to predict response to immunotherapy in cancer: volume II—clinical validation and regulatory considerations. J Immunother Cancer. 2016;4:77.

Article  PubMed  PubMed Central  Google Scholar 

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol. 2017;24:235–51.

Article  PubMed  PubMed Central  Google Scholar 

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol. 2017;24:311–35.

Article  PubMed  PubMed Central  Google Scholar 

McAlpine JN, Porter H, Köbel M, Nelson BH, Prentice LM, Kalloger SE, et al. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod Pathol. 2012;25:740–50.

Article  CAS  PubMed  Google Scholar 

Clarke B, Tinker AV, Lee C-H, Subramanian S, van de Rijn M, Turbin D, et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol. 2009;22:393–402.

Article  CAS  PubMed  Google Scholar 

Hwang W-T, Adams SF, Tahirovic E, Hagemann IS, Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol. 2012;124:192–8.

Article  PubMed  Google Scholar 

Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203–13.

Article  CAS  PubMed  Google Scholar 

Hussein YR, Weigelt B, Levine DA, Schoolmeester JK, Dao LN, Balzer BL, et al. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations. Mod Pathol. 2015;28:505–14.

Article  CAS  PubMed  Google Scholar 

Howitt BE, Shukla SA, Sholl LM, Ritterhouse LL, Watkins JC, Rodig S, et al. Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1. JAMA Oncol. 2015;1:1319.

Article  PubMed  Google Scholar 

Shia J, Black D, Hummer AJ, Boyd J, Soslow RA. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol. 2008;39:116–25.

Article  CAS  PubMed  Google Scholar 

Denkert C, von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, et al. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. J Clin Oncol. 2015;33:983–91.

Article  CAS  PubMed  Google Scholar 

Lokuhetty D, et al. Female genital tumours. WHO classification of tumours. 5th ed. Lyon: Internal Agency for Research on Cancer (IARC); 2020.

Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.

Article  Google Scholar 

Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28:105–13.

Article  CAS  PubMed  Google Scholar 

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs working group 2014. Ann Oncol. 2015;26:259–71.

Article  CAS  PubMed  Google Scholar 

Kojima YA, Wang X, Sun H, Compton F, Covinsky M, Zhang S. Reproducible evaluation of tumor-infiltrating lymphocytes (TILs) using the recommendations of International TILs working group 2014. Ann Diagn Pathol. 2018;35:77–9.

Article  PubMed  Google Scholar 

Price JH, Heath AB, Sunter JP, Sinha DP, Monaghan JM. Inflammatory cell infiltration and survival in squamous cell carcinoma of the vulva. BJOG. 1988;95:808–13.

Article  CAS  Google Scholar 

Rowley KC, Gallion HH, Donaldson ES, van Nagell JR, Higgins RV, Powell DE, et al. Prognostic factors in early vulvar cancer. Gynecol Oncol. 1988;31:43–9.

Article  CAS  PubMed  Google Scholar 

Husseinzadeh N, Wesseler T, Schellhas H, Nahhas W. Significance of lymphoplasmocytic infiltration around tumor cell in the prediction of regional lymph node metastases in patients with invasive squamous cell carcinoma of the vulva: a clinicopathologic study. Gynecol Oncol. 1989;34:200–5.

Article  CAS  PubMed  Google Scholar 

Bjerregaard B, Andreasson B, Visfeldt J, Bock JE. The significance of histology and morphometry in predicting lymph node metastases in patients with squamous cell carcinoma of the vulva. Gynecol Oncol. 1993;50:323–9.

Article  CAS  PubMed  Google Scholar 

Preti M, Micheletti L, Barbero M, Ghiringhello B, Valentino MC, Nicolaci P, et al. Histologic parameters of vulvar invasive carcinoma and lymph node metastases. J Reprod Med. 1993;38:28–32.

CAS  PubMed  Google Scholar 

Abrão FS, Baracat EC, Marques AF, Abrão MS, Torloni H, Coelho FR, et al. Carcinoma of the vulva. Clinicopathologic factors involved in inguinal and pelvic lymph node metastasis. J Reprod Med. 1990;35:1113–6.

PubMed  Google Scholar 

de Jong RA, Toppen NL, ten Hoor KA, Boezen HM, Kema IP, Hollema H, et al. Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma. Gynecol Oncol. 2012;125:186–93.

Article  PubMed  Google Scholar 

Sznurkowski JJ, Żawrocki A, Emerich J, Biernat W. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2011;21:717–21.

Article  PubMed  Google Scholar 

Raspollini MR, Asirelli G, Taddei GL. Analysis of lymphocytic infiltrate does not help in prediction of vulvar squamous cell carcinoma arising in a background of lichen sclerosus. Int J Gynecol Obstet. 2008;100:190–1.

Article  CAS  Google Scholar 

Sznurkowski JJ, Żawrocki A, Emerich J, Sznurkowska K, Biernat W. Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests. Gynecol Oncol. 2011;122:307–12.

Article  CAS  PubMed  Google Scholar 

Kortekaas KE, Santegoets SJ, Abdulrahman Z, van Ham VJ, van der Tol M, Ehsan I, et al. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status. J Immunother Cancer. 2019;7:236.

Article  PubMed  PubMed Central  Google Scholar